PMHS Stock Polomar Health Services (PMHS, $0.2) was a top gainer this month, soaring +152.5%
at Tickeron.com
Loading...
Polomar Health Services (PMHS, $0.2) was one of the top gainers for the month, rising +1 to $0.2 per share. A.I.dvisor analyzed 22 stocks in the Drugstore Chains Industry for the month ending December 23, 2025 and discovered that of them (6) exhibited an Uptrend while of them (3) exhibited a Downtrend.
PMHS's RSI Indicator is staying in overbought zone for 1 day
Watch for a price pull-back in the near future.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Aroon Indicator for PMHS entered a downward trend on December 23, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 49 cases where PMHS's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on December 03, 2025. You may want to consider a long position or call options on PMHS as a result. In of 77 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for PMHS just turned positive on December 09, 2025. Looking at past instances where PMHS's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .
PMHS moved above its 50-day moving average on December 23, 2025 date and that indicates a change from a downward trend to an upward trend.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. PMHS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PMHS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 96, placing this stock better than average.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.730) is normal, around the industry mean (3.052). P/E Ratio (0.000) is within average values for comparable stocks, (41.387). PMHS's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.138). Dividend Yield (0.000) settles around the average of (0.027) among similar stocks. PMHS's P/S Ratio (151.515) is very high in comparison to the industry average of (11.390).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
Advertisement